Skip to main contentCambridge University Reporter

No 6321

Wednesday 16 October 2013

Vol cxliv No 4

pp. 32–37

Graces

Graces submitted to the Regent House on 16 October 2013

The Council submits the following Graces to the Regent House. These Graces, unless they are withdrawn or a ballot is requested in accordance with the regulations for Graces of the Regent House (Statutes and Ordinances, p. 103), will be deemed to have been approved at 4 p.m. on Friday, 25 October 2013.

1. That the recommendations in paragraph 14 of the Second-stage Report of the Council, dated 12 July 2013, on the alteration and refurbishment of the Arup Building on the New Museums site (Reporter, 6316, 2012–13, p. 751) be approved.

2. That the recommendations in paragraph 5 of the Report of the General Board, dated 10 July 2013, on the establishment of two Professorships in the Department of Clinical Neurosciences (Reporter, 6316, 2012–13, p. 753) be approved.

3. That, on the recommendation of the General Board, the Professorship of Health Services Research be retitled the RAND Professorship of Health Services Research.1

4. That a Bluegnome Molecular Genetic Pathology Fund be established in the University, to be governed by the following regulations:

Bluegnome Molecular Genetic Pathology Fund

1. The sum of £750,000 received by the University, via Cambridge Enterprise, from the sale of shares held on behalf of the Mammalian Molecular Genetics Group, Department of Pathology shall form a fund entitled the Bluegnome Molecular Genetic Pathology Fund. This title acknowledges the key role played by the Mammalian Molecular Genetics Group in the early development of Bluegnome Ltd. The income of the Fund shall be used solely for the benefit of the Department of Pathology and its purposes as provided for in Regulation 3.

2. The Managers of the Fund shall comprise:

(a)the Head of the Department of Pathology or her or his deputy;

(b)the Head of the Division of Cellular and Molecular Pathology in the Department of Pathology or her or his deputy;

(c)three persons appointed by the Faculty Board of Biology in the Michaelmas Term to serve for a period of four years from 1 January following their appointment.

3. The income of the Fund shall be used as the Managers shall from time to time determine for any one or more of the following purposes:

(a)the support of (i) posts, (ii) Research Fellowships, and (iii) Research Studentships, within the Department of Pathology;

(b)the repair and maintenance of equipment or purchase of new equipment in the Department; and

(c)the overall support and enhancement of the quality and breadth of (i) research implemented within the Department including provision of new (and improvement of existing) premises and facilities appropriate for such research; and (ii) research initiated or sponsored by the Department.

4. Any unexpended income of the Fund in any financial year may either be added to the capital of the Fund or accumulated for use as income in any one or more subsequent years, as determined by the Managers.

5. The Managers may accept additional sums from time to time for the same purpose and add them to the capital of the Fund.

Footnotes

  • 1Statutes and Ordinances, p. 732. The proposed change in name recognizes the contribution which RAND Europe has agreed to make towards the costs of the Professorship for the tenure of Professor Martin Roland. The proposed change has the agreement of Professor Roland.


J. W. NICHOLLS, Registrary

END OF THE OFFICIAL PART OF THE ‘REPORTER’